VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
88 hedge funds and large institutions have $1.31B invested in Verona Pharma in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
29% more funds holding
Funds holding: 68 → 88 (+20)
0.33% more ownership
Funds ownership: 8.93% → 9.26% (+0.33%)
4% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 25
Holders
88
Holding in Top 10
16
Calls
$29.8M
Puts
$6.29M
Top Buyers
| 1 | +$46M | |
| 2 | +$29.9M | |
| 3 | +$26.9M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$18.7M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$9.43M |
Top Sellers
| 1 | -$29.3M | |
| 2 | -$21.7M | |
| 3 | -$11.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.11M |